CircNova, a Michigan-based biotechnology startup, has successfully raised $3.3 million in seed funding to propel its innovative AI-driven circular RNA (circRNA) therapeutic platform. This funding round was led by South Loop Ventures, a venture capital firm focused on diversity, with additional investments from Dug Song, Union Heritage Ventures, Michigan Rise, Invest Detroit Ventures, Spark Capital, and Kalamazoo Forward Ventures. The infusion of capital aims to accelerate CircNova’s mission to develop novel RNA-based therapies targeting diseases that have remained challenging to treat.
Background on CircNova & Founders
Founded in May 2023, CircNova is the brainchild of CEO Crystal Brown and Chief Scientific Officer Joe DeAngelo.
